Ramy Sedhom: Premenopausal HR+ Patients Could Be Treated While Pursuing Family Goals
Ramy Sedhom and Ann Partridge

Ramy Sedhom: Premenopausal HR+ Patients Could Be Treated While Pursuing Family Goals

Ramy Sedhom, Director of Medical Oncology and Palliative Care at Penn Medicine Princeton Health, University of Pennsylvania Health System, shared a post on X:

“Helpful reflections on the POSITIVE trial – summary – premenopausal hormone receptor-positive patients could be safely treated for their cancer while pursuing family goals.”

Read Here

Other articles featuring Ramy Sedhom on OncoDaily.